VICTORIA SHAVER: Open Payments
NPI 1962055590 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,090 in 54 payments from 14 companies in 2025. Trend: 2023 $600 · 2024 $1,000 · 2025 $1,090
Food & beverage: $1,090
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $189 |
| Medtronic, Inc. | 8 | $156 |
| Amgen Inc. | 7 | $121 |
| Merck Sharp & Dohme LLC | 5 | $116 |
| PFIZER INC. | 5 | $91 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $82 |
| E.R. Squibb & Sons, L.L.C. | 4 | $78 |
| Novartis Pharmaceuticals Corporation | 3 | $73 |
| Esperion Therapeutics, Inc. | 3 | $53 |
| AstraZeneca Pharmaceuticals LP | 3 | $49 |
Products named: Wegovy, REPATHA, VERQUVO, JARDIANCE, MYCARELINK, CAMZYOS, LEQVIO, ELIQUIS.
Industry payments across GA — which companies pay providers there.
